Coming to your inbox on the 18th November - make sure it doesn't get buried under all the other very important emails!

We are due to launch the annual census of Consultants in Diabetes and Endocrinology. This is being done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London who are also project managing this census.

There has never been a more important time to gather information about how were all working and the impact our jobs have on our lives.

It is vital that all health care professionals understand why cardiac and renal risk require BOTH measurement of urine albumin creatinine ratios AS WELL as eGFR.

Cardiology, Renal and Metabolic (CaReMe) group have produced a very helpful leaflet for people with diabetes on SGLT-2 inhibitors.

SGLT-2 inhibitors are being increasingly used in people with type 2 diabetes to improve diabetes control with the added benefits of weight loss, reduction in BP, reduction in admission from heart failure, reduction in cardiovascular and overall mortality and reduction in renal deterioration.

Free insulin safety training e-leaning module launched

NHS trusts and Primary Care Networks are being urged to roll out a new online insulin safety course which has been launched with the aim of reducing insulin error by providing free education to healthcare professionals.

According to the results from the latest National Diabetes Inpatient Audit¹, two in five people with diabetes on insulin (40 per cent) experience an error related to the administration of the drug while in hospital, with errors also reported in the community setting.

This is the third ABCD webinar in a series of four.

In this webinar, the focus will be the challenges facing diabetes services as they adapt to life after Covid. The ABCD risk stratification model and the thought that went into it will be discussed along with a talk about how technology may help in the recovery process.